Gautam Adani becomes world’s 2nd richest person, beats France’s Bernard Arnault as group stocks rally
Billionaire Gautam Adani on Friday briefly surpassed French business magnate Bernard Arnault to become the world’s second richest person. Adani and his family’s net worth surged to $155.4 billion, surpassing that of LVMH Mo?t Hennessy – Louis Vuitton SE, co-founder, chairman, CEO Arnault, according to the Forbes Real-Time Billionaires List. Adani is now just behind Tesla chief Elon Musk whose net worth stands at $273.5 billion. There are now two Indians in the top 10 in the Forbes list with Mukesh Ambani ranked 8th with a fortune of $92.2 billion. Amazon founder Jeff Bezos is at number three with a net worth of $149.7 billion, followed by Microsoft founder Bill Gates ($105.3 billion), Larry Ellison ($98.3 billion) and ace Wall Street investor Warren Buffet ($96.5 billion).
PM Modi calls for transit access among SCO nations
Prime Minister?Narendra Modi?on Friday called upon SCO member states to give transit access to each other and pitched for boosting connectivity for ensuring resilient supply chains for the region.
In his address at the SCO summit in this historic city, Modi also said that India’s economy is expected to grow at 7.5 per cent this year, which will be the highest among the world’s major economies.
Read More: https://www.financialexpress.com/defence/pm-modi-calls-for-transit-access-among-sco-nations/2669483/
Patanjali to launch 4 IPOs, to list Ayurved, Wellness, Medicine, Lifestyle in few years; 3 more listings later
Baba Ramdev’s?Patanjali?group announced the initial public offering (IPO) plans for four group companies at a press conference on Friday. In the coming few years, the company will launch four IPOs — Patanjali Ayurved, Patanjali Wellness and Patanjali Medicine and Patanjali Lifestyle. Baba Ramdev also said that the company plans to have at least 5-7 listed companies from the group. Currently, Patanjali’s group turnover is at Rs 40,000 crore. “We are confident that it will be Rs 1 lakh crore in the next five years,” Ramdev said. The company aims to reach a market share of Rs 5 lakh crore with these IPOs.
Patanjali Foods share price was trading 0.5 per cent up at Rs 1,349 apiece on BSE on Thursday. In the past one month the stock price has surged 20 per cent, and 30 per cent in the last six months. Baba Ramdev also said that in the coming days, Patanjali will provide 5 lakh crore employment opportunities. The company has also planned to open 1 lakh Patanjali Wellness stores.
Warning signs flashing for global recession in 2023, as interest rate hikes threaten economic growth
The world economies may fall into a global recession next year amid aggressive monetary policy tightening by central banks to tame inflation, the World Bank said. Several historical indicators of global recessions are already flashing warnings, it said in a new study, adding that the global economy is now in its steepest slowdown, following a post-recession recovery since 1970. “As central banks across the world simultaneously hike interest rates in response to inflation, the world may be edging toward a global recession in 2023,” the World Bank said.
Aside from recession, a string of financial crises in emerging markets and developing economies is also likely to do them “lasting harm”, the report said. Global consumer confidence has already suffered a much sharper decline than in the run-up to previous global recessions. Major central banks around the world have been raising interest rates this year with a degree of synchronicity that has not been seen over the past 50 years, and this trend is likely to continue well into next year, according to the World Bank report.
领英推荐
Royal Enfield Hunter 350 becomes second best-selling RE within a month of launch
Royal Enfield launched the much-anticipated?Hunter 350?in India last month. The all-new Royal Enfield Hunter 350 is currently the company’s most affordable motorcycle and is priced from Rs 1.49 lakh, ex-showroom. Now, it had a really great start as the Hunter 350 became the second best-selling Royal Enfield motorcycle in India within a month of its official launch.
Apple’s Mixed Reality Headsets may let you see invisible things
Apple is working on its Mixed Reality (MR) headset that could let users view?invisible things. According to the report, the new headset could?provide users?with “visualization of non-visible phenomena” meaning?things that are invisible to naked eyes. It suggests that Apple will use additional signals to activate a function that will let a wearer see electromagnetic signals like Wi-Fi or gas leaks. Interestingly, the list doesn’t end here, it could also let musicians tune their instruments by seeing the sound waves.
The headset could also help in detecting possible fires as it might track heat patterns as well. It will also allow users to see inside cupboards by creating an augmented reality (AR) overlay.
India has a big role to play in SCO: Uzbekistan’s SCO coordinator
All eyes are on India as Prime Minister?Narendra Modi?touched down in Samarkand for nearly 24 hours of intense high-wire diplomacy. Being an emerging power and the world’s fifth largest economy, there are high expectations from India as Uzbekistan and many key countries in the region want India to play a bigger role in the eight-nation Shanghai Cooperation Organisation. Manish Chand, of Centre for Global India Insights (CGII), a global think tank focused on global affairs, caught up with Uzbekistan National Coordinator H.E. Rakhmatullah Nurimbetov on the sidelines of the SCO summit in Samarkand.
AstraZeneca’s cocktail antibody treatment gets recommendation from EU for COVID-19
AstraZeneca?on Friday announced that its Evusheld (tixagevimab and cilgavimab, formerly), a long-acting antibody combination, has been recommended for marketing authorisation in the European Union (EU) for the treatment of adults and adolescents (aged 12 years and older weighing at least 40 kg) with COVID?19. According to the company, this is for those people who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID?19.
“The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its positive opinion on results from the TACKLE Phase III COVID-19 treatment trial which showed one intramuscular (IM) dose of Evusheld provided clinically and statistically significant protection against progression to severe COVID-19 or death from any cause compared to placebo. Evusheld treatment earlier in the disease course led to more favourable outcomes,” the company stated on Friday.
Aspiring Corporate Director / Management Consultant / Corporate Leader
2 年Congrats. & Best wishes, to Mr Gautam Adani ji and '#Adani #Pariwar' and Adani Group ..., to achieve, many more milestones...on the way! Thanks for sharing, Financial Express (India) #AdaniGroup Syed Awees